AJP - Endocrinology and Metabolism, Vol 257, Issue 2 E241-E246, Copyright © 1989 by American Physiological Society

ARTICLES

Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans

L. Luzi and R. A. DeFronzo
Division of Diabetes, University of Texas Health Science Center, San Antonio 78284-7886.

To examine the importance of first-phase insulin secretion on total body glucose homeostasis, six normal subjects (age, 24 +/- 1 yr; ideal body wt, 100 +/- 1%) received three hyperglycemic (+75 mg/100 ml) clamp studies in combination with [3-3H]glucose: study I, 150 min hyperglycemic clamp; study II, hyperglycemic clamp plus somatostatin (6 micrograms/min) plus basal glucagon replacement (0.4 ng.kg-1.min-1) plus an insulin infusion designed to mimic only the second phase of insulin secretion; and study III, hyperglycemic clamp plus somatostatin plus basal glucagon plus an insulin infusion designed to mimic both the first and second phase of insulin secretion. Basal plasma C-peptide concentrations averaged 0.21 +/- 0.01 pmol/ml in the three study protocols. In study I the plasma C-peptide response demonstrated an early burst within the first 10 min followed by a gradually increasing phase of C-peptide secretion that lasted until the end of the study. In studies II and III plasma C-peptide declined within the first 10 min after somatostatin was started and averaged 0.06 +/- 0.01 and 0.05 +/- 0.01 pmol/min, respectively. Basal hepatic glucose production (2.3 +/- 0.2 mg.kg-1.min-1) was suppressed by 90% at 20 min and remained suppressed thereafter in studies I and III. In contrast, in study II hepatic glucose production was inhibited by only 50% (1.1 +/- 0.2 mg.kg-1.min-1) at 60 min (P less than 0.01 vs. studies I and III) and remained incompletely suppressed even after 150 min.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G. F Anhe, T. C A Nogueira, J. E Nicoletti-Carvalho, C. Lellis-Santos, H. C Barbosa, J. Cipolla-Neto, J. R Bosqueiro, A. C Boschero, and S. Bordin Signal transducer and activator of transcription 3-regulated sarcoendoplasmic reticulum Ca2+-ATPase 2 expression by prolactin and glucocorticoids is involved in the adaptation of insulin secretory response during the peripartum period J. Endocrinol., October 1, 2007; 195(1): 17 - 27. [Abstract] [Full Text] [PDF]

				C. Everett-Grueter, D. S. Edgerton, E. P. Donahue, S. Vaughan, C. A. Chu, D. K. Sindelar, and A. D. Cherrington The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E449 - E459. [Abstract] [Full Text] [PDF]

				C. A. DiCostanzo, M. C. Moore, M. Lautz, M. Scott, B. Farmer, C. A. Everett, J. G. Still, A. Higgins, and A. D. Cherrington Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E46 - E52. [Abstract] [Full Text] [PDF]

				A. Caumo and L. Luzi First-phase insulin secretion: does it exist in real life? Considerations on shape and function Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E371 - E385. [Abstract] [Full Text] [PDF]

				L. S. Cozma, S. D. Luzio, G. J. Dunseath, K. W. Langendorg, T. Pieber, and D. R. Owens Comparison of the Effects of Three Insulinotropic Drugs on Plasma Insulin Levels After a Standard Meal Diabetes Care, August 1, 2002; 25(8): 1271 - 1276. [Abstract] [Full Text] [PDF]

				C. C. Jensen, M. Cnop, R. L. Hull, W. Y. Fujimoto, S. E. Kahn, and the American Diabetes Association GENNID Study Gro {beta}-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S. Diabetes, July 1, 2002; 51(7): 2170 - 2178. [Abstract] [Full Text] [PDF]

				J.-C. Henquin, N. Ishiyama, M. Nenquin, M. A. Ravier, and J.-C. Jonas Signals and Pools Underlying Biphasic Insulin Secretion Diabetes, February 1, 2002; 51(90001): S60 - 67. [Abstract] [Full Text] [PDF]

				A. D. Cherrington, D. Sindelar, D. Edgerton, K. Steiner, and O. P. McGuinness Physiological Consequences of Phasic Insulin Release in the Normal Animal Diabetes, February 1, 2002; 51(90001): S103 - 108. [Abstract] [Full Text] [PDF]

				S. Del Prato, P. Marchetti, and R. C. Bonadonna Phasic Insulin Release and Metabolic Regulation in Type 2 Diabetes Diabetes, February 1, 2002; 51(90001): S109 - 116. [Abstract] [Full Text] [PDF]

				G. Pacini, K. Thomaseth, and B. Ahren Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E693 - E703. [Abstract] [Full Text] [PDF]

				P. N. Båvenholm, J. Pigon, C.-G. Östenson, and S. Efendic Insulin Sensitivity of Suppression of Endogenous Glucose Production Is the Single Most Important Determinant of Glucose Tolerance Diabetes, June 1, 2001; 50(6): 1449 - 1454. [Abstract] [Full Text]

				B. Ahren and G. Pacini Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E701 - E707. [Abstract] [Full Text] [PDF]